Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2011-07-26

Clinical Trial Update: How Airway Remodeling and Hyperresponsiveness Contribute to Airflow Obstruction in Asthma

View source ↗

Summary

A clinical trial exploring how airway remodeling and hyperresponsiveness contribute to airflow obstruction in asthma has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Asthma | Status: WITHDRAWN